Debra Yu, MDManaging Director, Head of Cross-Border Healthcare Investment Banking at China Renaissance
Dr. Debra Yu has 30 years of experience in the life sciences industry as a VC investor, a company executive and a strategic advisor to companies worldwide. Prior to China Renaissance, she was Managing Director of Labrador Advisors where she executed numerous successful business development transactions in the US and in China. Earlier, Debra was General Partner of Delphi Ventures and Managing Director of Bay City Capital, and helped architect and co-lead the Pfizer venture capital group. To engage her passion and interest in the evolving landscape of China life sciences, she joined WuXi Apptec in 2008. Debra also held positions at McKinsey & Co. in New York and London, and began her career as an analyst at Morgan Stanley. She also served as the Mid-Atlantic Regional Chairperson for BayHelix for several years prior to joining the BayHelix Board in 2018. She received a BA with high honors in Molecular Biology from Princeton University and earned an MD from Harvard Medical School.